03_dorrepaal_karin_dr_01

Almirall appoints first woman to its Board

pharmafile | November 21, 2012 | Appointment | Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Almirall 

Karin Louise Dorrepaal is the first woman to join Almirall’s ten-member Board of directors.

Dorrepaal, who is Dutch, has extensive international experience in the pharmaceutical sector and in consultancy. The appointment takes effect as of 1 January and will be ratified in Almirall’s next Annual General Meeting.

Dorrepaal’s career spans over 25 years during which she has held top-level positions in the pharmaceutical sector and the international strategic consultancy area.  

Advertisement

She has led various pharmaceutical business model transformation processes and currently holds non-executive positions in companies related to the healthcare sector and consultancy. 

Related Content

Almirall licenses Novo Nordisk’s anti-IL-21 monoclonal antibody for dermatology treatment

Almirall has announced that it has entered into an exclusive license agreement with Novo Nordisk …

Almirall gains EC approval of Ebglyss for moderate-to-severe atopic dermatitis

Almirall has announced that the European Commission (EC) has approved Ebglyss (lebrikizumab) for the treatment …

The Gateway to Local Adoption Series

Latest content